Bionano Genomics Inc (BNGO): Next-Year EPS Estimate 58.01%
As of 2026-06-04, Bionano Genomics Inc (BNGO) has a next-year EPS growth estimate of 58.01%.
BNGO was first flagged by our screen on 2026-05-31, when analyst consensus for its next-year EPS growth was revised from 57.31% to 58.01%. Current-year growth is projected at 64.49%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- EPS growth next year
- 58.01%
- EPS growth this year
- 64.49%
- EPS next quarter (est)
- -$0.69
- Last price
- $1.26
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 58.01% | 64.49% | -$0.69 | $1.26 |
| 2026-06-03 | 58.01% | 64.49% | -$0.69 | $1.30 |
| 2026-06-02 | 58.01% | 64.49% | -$0.69 | $1.26 |
| 2026-06-01 | 58.01% | 64.49% | -$0.69 | $1.25 |
| 2026-05-31 | 58.01% | 64.49% | -$0.69 | $1.24 |
| 2026-05-28 | 57.31% | 60.03% | -$0.80 | $1.25 |
| 2026-05-27 | 57.31% | 60.03% | -$0.80 | $1.23 |
| 2026-05-26 | 57.31% | 60.03% | -$0.80 | $1.22 |
| 2026-05-25 | 57.31% | 60.03% | -$0.80 | $1.24 |
| 2026-05-24 | 57.31% | 60.03% | -$0.80 | $1.24 |
| 2026-05-21 | 57.31% | 60.03% | -$0.80 | $1.23 |
| 2026-05-20 | 57.31% | 60.03% | -$0.80 | $1.24 |
| 2026-05-19 | 57.31% | 60.03% | -$0.80 | $1.17 |
| 2026-05-18 | 57.31% | 60.03% | -$0.80 | $1.16 |
| 2026-05-17 | 57.31% | 60.03% | -$0.80 | $1.15 |
| 2026-05-14 | 57.31% | 60.03% | -$0.80 | $1.19 |
| 2026-05-13 | 57.31% | 60.03% | -$0.88 | $1.31 |
| 2026-05-12 | 57.31% | 60.03% | -$0.88 | $1.26 |
| 2026-05-11 | 57.31% | 60.03% | -$0.88 | $1.27 |
| 2026-05-10 | 57.31% | 60.03% | -$0.88 | $1.29 |
| 2026-05-07 | 57.31% | 60.03% | -$0.88 | $1.33 |
| 2026-05-06 | 57.31% | 60.03% | -$0.88 | $1.27 |
| 2026-05-05 | 57.31% | 60.03% | -$0.88 | $1.24 |
| 2026-05-04 | 57.31% | 60.03% | -$0.88 | $1.24 |
| 2026-05-03 | 57.31% | 60.03% | -$0.88 | $1.18 |
| 2026-04-30 | 57.31% | 60.03% | -$0.88 | $1.16 |
| 2026-04-29 | 57.31% | 60.03% | -$0.88 | $1.16 |
| 2026-04-28 | 57.31% | 60.03% | -$0.88 | $1.19 |
| 2026-04-27 | 57.31% | 60.03% | -$0.88 | $1.23 |
| 2026-04-26 | 57.31% | 60.03% | -$0.88 | $1.21 |
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Bionano Genomics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Bionano Genomics Inc (BNGO) has a next-year EPS growth estimate of 58.01%, based on analyst consensus.
When was the latest EPS estimate revision for BNGO?▾
The most recent revision occurred on 2026-05-31, when analysts adjusted the next-year EPS growth estimate from 57.31% to 58.01%.
What sector and industry does Bionano Genomics Inc belong to?▾
Bionano Genomics Inc operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BNGO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Bionano Genomics Inc (BNGO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports